Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Objective and subjective measures of dalfampridine efficacy in clinical practiceSylvia Klineova, Rebecca Farber, Joshua Friedman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 25, 2022
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trialsEva Mm Strijbis, Pavle Repovic, Jop Mostert, et al.
European Journal of Neurology|June 12, 2023
Threshold definitions for significant change on the timed 25-foot walk and nine-hole peg test in primary progressive multiple sclerosisMarcus W Koch, Pavle Repovic, Jop Mostert, et al.
Multiple Sclerosis and Related Disorders|December 3, 2022
The nine hole peg test as an outcome measure in progressive MS trialsMarcus W Koch, Pavle Repovic, Jop Mostert, et al.
Brain : a Journal of Neurology|February 1, 2015
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosisJames D Weisfeld-Adams, Ilana B Katz Sand, Justin M Honce, et al.
Multiple Sclerosis and Related Disorders|April 21, 2015
Natalizumab reduces relapse clinical severity and improves relapse recovery in MSFred D Lublin, Gary Cutter, Gavin Giovannoni, et al.
Neurology|May 31, 2020
The 2013 clinical course descriptors for multiple sclerosis: A clarificationFred D Lublin, Timothy Coetzee, Jeffrey A Cohen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE datasetJop Mostert, Eva M Strijbis, Miguel D'Haeseleer, et al.
Pageof 13